Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;35(3):e183-e185.
doi: 10.1111/jdv.17051. Epub 2020 Dec 21.

Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant - a cross-sectional study

D Fernandez-Nieto  1 , D Ortega-Quijano  1 , A Suarez-Valle  1 , J Jimenez-Cauhe  1 , P Jaen-Olasolo  1 , M Fernandez-Guarino  1
Affiliations

Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant - a cross-sectional study

D Fernandez-Nieto et al. J Eur Acad Dermatol Venereol. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

References

    1. Galván Casas C, Català A, Carretero Hernández G et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183: 71–77. - PMC - PubMed
    1. Guan W‐J, Ni Z‐Y, Hu Y et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708–1720. - PMC - PubMed
    1. Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol 2020; 34: e212–e213. - PubMed
    1. Méndez Maestro I, Peña Merino L, Udondo González Del Tánago B et al. Skin manifestations in patients hospitalized with confirmed COVID‐19 disease: a cross‐sectional study in a tertiary hospital. Int J Dermatol 2020; 59: 1353–1357. - PMC - PubMed
    1. Giavedoni P, Podlipnik S, Pericàs JM et al. Skin manifestations in COVID‐19: prevalence and relationship with disease severity. J Clin Med 2020; 9: 3261. - PMC - PubMed